Document is current
Any future updates will be listed below
-
Authors
Campbell, Aoife
Morris, Gareth
Heller, Janosch P.
Langa, Elena
Brindley, Elizabeth
Worm, Jesper
Jensen, Mads Aaboe
Miller, Meghan T.
Henshall, David C.
Reschke, Cristina R.
-
Funding
Funding for this research was provided by:
Science Foundation Ireland (16/RC/3948)
Science Foundation Ireland (13/IA/1891)
Seventh Framework Programme (602130)
H2020 Marie Skłodowska-Curie Actions (IF-2018 840262)
H2020 Marie Skłodowska-Curie Actions (H2020-MSCA-IF-2017 798644)
- License Information
-
More Information
Article History
Received: 17 April 2020
Accepted: 4 December 2020
First Online: 11 January 2021
Competing interests
: The Royal College of Surgeons in Ireland (DH) holds a patent for the inhibition of microRNA-134 for the treatment of seizure-related disorders and other neurologic injuries (US 9,803,200 B2). JW, MAJ and MTM are employees of Hoffman-La Roche Ltd. All other authors have no competing interests.
